| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |